Product Information

BRIMONIDINE-TIMOLOL 0.2%-0.5% is a generic product labeled by Florida Pharmaceutical Products, LLC, priced at $2.0756 per ML under NDC 71921018815. Its NADAC has been published 150 times since Jan 10, 2024.

FDA first approved this application on Oct 4, 2022. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

BRIMONIDINE-TIMOLOL 0.2%-0.5%

Brimonidine tartrate and Timolol maleate
$2.0756per ML

Strength

2; 5 mg/mL; mg/mL

NDC

71921018815

Classification

Generic

Dosage Form

SOLUTION

Route

OPHTHALMIC

Effective Date

11/18/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA201949

FDA Approved

10/4/2022

TE Code

AB

On Market Since

11/23/2023

Pharmacological Classes

Adrenergic alpha-Agonists
Adrenergic beta-Antagonists
alpha-Adrenergic Agonist
beta-Adrenergic Blocker

Price Statistics

The NADAC for BRIMONIDINE-TIMOLOL 0.2%-0.5% has been published 150 times since Jan 10, 2024, and over the history we have for it it has declined 87.9%. The table below summarizes its recorded NADAC range and movement.

Current price$2.0756 per ML
All-time high$17.1668 (Jan 10, 2024)
All-time low$1.8390 (Aug 19, 2026)
52-week high$6.2321
52-week low$1.8390
Median price$6.8892
Average price$6.7630
Largest weekly change+75.9% (Aug 21, 2024)
Weeks tracked150
Tracking sinceJan 10, 2024

Price History

1W

+1.7%

1M

+5.3%

3M

+12.9%

6M

-12.9%

1Y

-66.7%

3Y

N/A

5Y

N/A

All

-87.9%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of BRIMONIDINE-TIMOLOL 0.2%-0.5%?

The current National Average Drug Acquisition Cost (NADAC) for BRIMONIDINE-TIMOLOL 0.2%-0.5%, manufactured by Florida Pharmaceutical Products, LLC, is $2.0756 per ML (NDC 71921018815), effective Nov 18, 2026.

How has the price of BRIMONIDINE-TIMOLOL 0.2%-0.5% changed over time?

Over the history we have for it, the NADAC for BRIMONIDINE-TIMOLOL 0.2%-0.5% has declined 87.9%. It has been tracked across 150 weekly CMS publications since Jan 10, 2024.

What are the highest and lowest recorded NADAC prices for BRIMONIDINE-TIMOLOL 0.2%-0.5%?

Since Jan 10, 2024, the NADAC for BRIMONIDINE-TIMOLOL 0.2%-0.5% has ranged from a low of $1.8390 (Aug 19, 2026) to a high of $17.1668 (Jan 10, 2024), with a median of $6.8892 per ML.

Are there cheaper alternatives to BRIMONIDINE-TIMOLOL 0.2%-0.5%?

1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as BRIMONIDINE-TIMOLOL 0.2%-0.5% in a comparable dosage form, but none are currently priced below it.

Who manufactures BRIMONIDINE-TIMOLOL 0.2%-0.5%?

BRIMONIDINE-TIMOLOL 0.2%-0.5% (NDC 71921018815) is labeled by Florida Pharmaceutical Products, LLC, and CMS classifies it as a generic product.